SymBio Pharmaceuticals Limited (TSE: 4582)
Health Care · Pharmaceuticals · JP
¥54.00
-3.57% today · -58.1% 1Y
SymBio Pharmaceuticals Limited (TSE: 4582) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $27.34M and employs 91 people.
Over the last twelve months the share price has lost 58.1%, trading between 52.00 and 229.00.
Tweenvest scores SymBio Pharmaceuticals Limited across four factors: quality 40/100, value 46/100. Its strongest factor is value.
4582 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $27.34M
- Revenue (TTM)
- $6.95M
- P/E
- —
- EPS
- -97.55
- Dividend yield
- —
- Beta (5Y)
- 0.55
- 52-week high
- ¥229.00
- 52-week low
- ¥52.00
- Avg volume (3M)
- —
- Shares outstanding
- 80.16M
- Employees
- 91
- Next earnings
- —
About SymBio Pharmaceuticals Limited
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
- ISIN
- JP3383050006
- Founded
- 2005
- Listed since
- Oct 20, 2011
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ZYUS Life Sciences CorporationTSXV: ZYUS | $28.22M | CA$0.50 | -16.67% |
| Context Therapeutics Inc.NasdaqCM: CNTX | $27.95M | $0.30 | -1.78% |
| Vidipha Central Pharmaceutical Joint Stock CompanyHOSE: VDP | $27.81M | ₫32,600.00 | -20.20% |
| BDH Industries LimitedBSE: 524828 | $27.69M | Rs465.55 | -3.45% |
| Seach Medical Group LtdTASE: SEMG | $27.26M | ₪2.60 | -7.71% |
| Lyka Labs LimitedNSEI: LYKALABS | $27.14M | Rs72.65 | -10.91% |
| Botanix Pharmaceuticals LimitedASX: BOT | $26.74M | AU$0.01 | -22.22% |
| Korea Arlico Pharm Co.,Ltd.KOSDAQ: A260660 | $26.68M | ₩2,340.00 | +3.54% |
Figures last refreshed Oct 11, 2026.